Overview

CD19 CAR-T Therapy for Elderly Patients With B-cell Non-Hodgkin's Lymphoma

Status:
Not yet recruiting
Trial end date:
2026-12-20
Target enrollment:
Participant gender:
Summary
A Study of CD19 CAR-T Therapy for Elderly Patients With B-cell Non-Hodgkin's Lymphoma.
Phase:
Early Phase 1
Details
Lead Sponsor:
Zhejiang University
Collaborator:
Yake Biotechnology Ltd.